TANEMURA Atsushi 種村篤

Researcher Number	50457016
Other IDs
Affiliation (Current)	2025: 大阪大学, 大学院医学系研究科, 准教授
Affiliation (based on the past Project Information) *help	2022 – 2024: 大阪大学, 大学院医学系研究科, 准教授 2020 – 2021: 大阪大学, 医学系研究科, 准教授 2016 – 2019: 大阪大学, 医学系研究科, 講師 2017: 大阪大学, 医学研究科, 講師 2016: 大阪大学, 大学院医学研究科, 助教 … More 2012 – 2013: 大阪大学, 大学院・医学系研究科, 助教 2012: 大阪大学, 大学院・医学研究科, 助教 2011 – 2012: 大阪大学, 医学(系)研究科(研究院), 助教 2010 – 2011: 大阪大学, 医学系研究科, 助教 Less
Review Section/Research Field	Principal Investigator Basic Section 53050:Dermatology-related / Dermatology Except Principal Investigator Tumor therapeutics / Dermatology / Tumor immunology / Clinical oncology
Keywords	Principal Investigator 白斑 / メラノサイト / 自己免疫 / 真皮線維芽細胞 / 自己免疫性白斑 / 色素細胞 / 抗原特異的免疫 / resident T cell / vitiligo / 色素細胞学 … More / 皮膚resident T細胞 / T細胞アナジー / 尋常性白斑 / 不活化センダイウイルス / 不活化センダイウイルスベクター / 抗腫瘍免疫 / 悪性黒色腫 / Hemagglutinating Virus of Japan-Envelope … More Except Principal Investigator 癌 / 免疫学 / がん / エフェクターT細胞 / 制御性T細胞 / 抗腫瘍免疫 / 分子標的治療 / 悪性黒色腫 / 免疫共抑制分子 / トランスレーショナルリサーチ / がん免疫療法 / 免疫制御 / CD4+制御性T細胞 / 抗腫瘍免疫応答 / 核酸医薬 / 遺伝子治療 / 遺伝子解析 / アポトーシス / HVJ Less

Analysis for anti-oxidative and immune-regulatory action in vitiligo fibroblastPrincipal Investigator
- Principal Investigator
  
  種村篤
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Osaka University
Analysis for skin microenvironmental change and character of melanocyte-specific resident T cellsPrincipal Investigator
- Principal Investigator
  
  Tanemura Atsushi
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53050:Dermatology-related
- Research Institution
  Osaka University
Development of a new strategy for cancer therapy based on RIG-I and MAVS signaling pathway
- Principal Investigator
  
  Kaneda Yasufumi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Osaka University
Analysis for melanocyte-specific T cells anargy system in autoimmune vitiligoPrincipal Investigator
- Principal Investigator
  
  Tanemura Atsushi
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Dermatology
- Research Institution
  Osaka University
Development of a novel molecular targeted therapy against acral melanomas
- Principal Investigator
  
  NAMIKI Takeshi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Dermatology
- Research Institution
  Tokyo Medical and Dental University
Activation of anti-tumor immune responses by the control of regulatory T cells
- Principal Investigator
  
  Nishikawa Hiroyoshi
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Nagoya University
  National Cancer Center Japan
  Osaka University
Analysis of suppressive mechanisms by regulatory T cells
- Principal Investigator
  
  NISHIKAWA Hiroyoshi
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor immunology
- Research Institution
  Osaka University
Establishment in evaluating antitumor immunity of inactivated HVJ-Eto malignant melanomaPrincipal Investigator
- Principal Investigator
  
  TANEMURA Atsushi
- Project Period (FY)
  2011 – 2012
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Dermatology
- Research Institution
  Osaka University
Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle
- Principal Investigator
  
  KANEDA Yasufumi
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Clinical oncology
- Research Institution
  Osaka University

All 2023 2018 2017 2016 2013 2012 2011

All Journal Article Presentation

[Journal Article] Novel real-time visualization of functional vitiligo skin lymphocytes attracting melanocytes in autologous cultured epidermis2023
- Author(s)
  Kazunori Yokoi, Rei Watanabe, Miki Kume, Tomoyo Tanaka, Atsushi Tanemura
- Journal Title
  
  Journal of Dermatology
  
  Volume: 50 Issue: 12 Pages: 1653-1655
- DOI
  10.1111/1346-8138.17011
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08670
[Journal Article] Melanocyte-specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.2023
- Author(s)
  Yokoi K, Watanabe R, Kume M, Yamane S, Tanaka A, Fujimoto M, Tanemura A
- Journal Title
  
  Journal of Dermatology
  
  Volume: 50 Issue: 5 Pages: 710-714
- DOI
  10.1111/1346-8138.16680
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08670, KAKENHI-PROJECT-23K24181
[Journal Article] Dysregulation of circular antigen-specific T cells anergy in autoimmune vitiligo.2018
- Author(s)
  Tanemura A, Yang L, Katayama I
- Journal Title
  
  Journal of Cosmetics Dermatological Sciences and Applications
  
  Volume: 8 Pages: 133-139
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K10154
[Journal Article] Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking anti-tumor immune responses in humans2013
- Author(s)
  Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, Katayama I, Ezoe S, Kanakura Y, Sato E, Fukumori Y, Karbach J, Jager E and Shakaguchi S
- Journal Title
  
  Proc. Natl. Acad Sci USA
  
  Volume: 110(44) Issue: 44 Pages: 17945-17950
- DOI
  10.1073/pnas.1316796110
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23300354
[Journal Article] Recent Advance and Development in Antitumor Effect of HVJ Envelope Vector in Malignant Melanoma; from Bench to Clinical Application2013
- Author(s)
  Atsushi Tanemura
- Journal Title
  
  Cancer Gene Therapy
  
  Volume: 未定
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23791268
[Presentation] Melanocyte-specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.2023
- Author(s)
  Yokoi K, Watanabe R, Kume M, Yamane S, Tanaka A, Fujimoto M, Tanemura A.
- Organizer
  The 3rd symposium for KSVPCR
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K08670
[Presentation] Recent advance in vitiligo research and clinics2023
- Author(s)
  Tanemura A
- Organizer
  The 3rd symposium for KSVPCR
- Invited
- Data Source
  KAKENHI-PROJECT-20K08670
[Presentation] 自家培養表皮シートを用いたメラノサイトを攻撃する白斑皮膚リンパ球のリアルタイムイメージング2023
- Author(s)
  横井一範、渡邊玲、久米美輝、田中朋代、藤本学、種村篤
- Organizer
  第5回日本白斑学会
- Data Source
  KAKENHI-PROJECT-20K08670
[Presentation] NUAK2 is over-expressed and DNA copy number is increased in acral melanoma: its significance on the survival of patients2017
- Author(s)
  Nojima K, Hayashi M, Funazumi M, Ishikawa M, Kaneko Y, Kawaguchi M, Suzuki T, Tanemura A, Katayama I, Mori T, Yamazaki N, Yokozeki H, Hearing VJ, Namiki T
- Organizer
  47th Annual Meeting of the European Society for Dermatologic Research, SALZBURG 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09760
[Presentation] NUAK2 is over-expressed and DNA copy number is increased in acral melanoma: its significance on the survival of patients2017
- Author(s)
  Nojima K, Hayashi M, Funazumi M, Ishikawa M, Kaneko Y, Kawaguchi M, Suzuki T, Tanemura A, Katayama I, Mori T, Yamazaki N, Yokozeki H, Hearing VJ, Namiki T
- Organizer
  42nd Annual Meeting of the Japanese Society for Investigative Dermatology, KOCHI 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09760
[Presentation] Regulatory T-cell induced anergic CD8+ T cells with suppressive function are novel targets of anti-CTLA-4 mAb2016
- Author(s)
  Danbee Ha, Hiroyoshi Nishikawa, Daisuke Sugiyama, Yuka Maeda, Dennis Adeegbe, Eichi Sato, Atsushi Tanemura, Ichiro Katayama, Shimon Sakaguchi
- Organizer
  第75回日本癌学会
- Place of Presentation
  パシフィコ横浜（神奈川県・横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26290054
[Presentation] Dysregulation of circulating T cells anergy might be involved in autoimmune disorder of vitiligo2016
- Author(s)
  Lingli Yang, Atsushi Tanemura, Kenichi Kato, Ichiro Katayama, Takayoshi Morita, Tomoka Iida, Atsushi Tanaka, Shimon Sakaguchi
- Organizer
  Vitiligo International Symposium
- Place of Presentation
  Rome, Italy
- Year and Date
  2016-12-02
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K10154
[Presentation] 進行性悪性黒色腫患者に対するヒトセンダイウイルスベクター(HVJ-E)を用いた臨床研究2013
- Author(s)
  種村篤
- Organizer
  第29回日本皮膚悪性腫瘍学会学術大会
- Data Source
  KAKENHI-PROJECT-23791268
[Presentation] エフェクター型制御性T細胞の選択的除去による抗原特異的免疫応答の増強2013
- Author(s)
  杉山大介, 西川博嘉, 前田優香, 西岡めぐみ, 種村篤, 片山一朗, 江副幸子, 金倉譲, 坂口志文
- Organizer
  第17回日本がん免疫学会
- Place of Presentation
  山口県宇部市
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells and augments anti-tumor immune responses in humans2013
- Author(s)
  Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, Katayama I, Ezoe S, Kanakura Y, Sato E, Fukumori Y, Karbach J, Jager E and Shakaguchi S
- Organizer
  21st Annual CRI International Cancer Immunotherapy Symposium
- Place of Presentation
  米国ニューヨーク市
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] 進行性悪性黒色腫患者に対するヒトセンダイウイルスベクター（HVJ-E）を用いた臨床研究2013
- Author(s)
  種村　篤
- Organizer
  日本皮膚悪性腫瘍学会学術大会
- Place of Presentation
  山梨
- Data Source
  KAKENHI-PROJECT-23791268
[Presentation] A Clinical Study Using the Hemagglutinating Virus of Japan-Envelope on Patients with Progressive Malignant Melanoma2013
- Author(s)
  Atsushi Tanemura
- Organizer
  8thWorld Congress of Melanoma
- Place of Presentation
  Hamburg in Germany
- Data Source
  KAKENHI-PROJECT-23791268
[Presentation] Selective depletion of effector-type CD4+regulatory T cells efficiently induces anti-tumor immune responses2013
- Author(s)
  杉山大介, 西川博嘉, 前田優香, 西岡めぐみ, 種村篤, 片山一朗, 江副幸子, 金倉譲, 坂口志文
- Organizer
  第72回日本癌学会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2013-10-04
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] A Clinical Study Using the Hemagglutinating Virus of Japan-Envelope on Patients with Progressive Malignant Melanoma2013
- Author(s)
  Atsushi Tanemura
- Organizer
  The World Congress of Melanoma
- Place of Presentation
  Hamburg
- Data Source
  KAKENHI-PROJECT-23791268
[Presentation] Immunosuppression by regulatory T cells in malignant melanoma2012
- Author(s)
  前田優香, 西川博嘉, 種村篤, 西岡めぐみ, 杉山大介, 片山一朗, 坂口志文
- Organizer
  第41回日本免疫学会
- Place of Presentation
  兵庫県神戸市
- Year and Date
  2012-12-06
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] Immunosuppression by regulatory T cells in malignant melanoma2012
- Author(s)
  Maeda Y, Nishikawa H, Tanemura A, Sugiyama D, Katayama I, Sakaguchi S
- Organizer
  Cancer Immunotherapy
- Place of Presentation
  米国ニューヨーク市
- Year and Date
  2012-10-02
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] Possible roles of regulatory T cells for the development of exhausted type CD8+ T cells in human melanoma tissue2011
- Author(s)
  Maeda Y, Nishikawa H, Tanemura A, Sugiyama D, Katayama I, Sakaguchi S
- Organizer
  日本免疫学会
- Place of Presentation
  千葉県千葉市
- Year and Date
  2011-11-27
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] Possible roles of regulatory T cells for the development of exhausted type CD8+T cells in human melanoma tissue2011
- Author(s)
  Maeda Y, Nishikawa H, Tanemura A, Sugiyama D, Katayama I, Sakaguchi S
- Organizer
  第40回日本免疫学会
- Place of Presentation
  幕張メッセ(千葉)
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] 皮膚悪性黒色腫局所における制御性T細胞の免疫抑制機構の解析2011
- Author(s)
  前田優香, 西川博嘉, 種村篤, 杉山大介, 片山一朗, 坂口志文
- Organizer
  日本がん免疫学会
- Place of Presentation
  大阪府大阪市
- Year and Date
  2011-07-01
- Data Source
  KAKENHI-PROJECT-23300354
[Presentation] 皮膚悪性黒色腫局所における制御性T細胞の免疫抑制機構の解析2011
- Author(s)
  前田優香、西川博嘉、種村篤、杉山大介、片山一朗、坂口志文
- Organizer
  第15回日本がん免疫学会
- Place of Presentation
  千里ライフサイエンスセンター(大阪)
- Data Source
  KAKENHI-PROJECT-23300354

1. KANEDA Yasufumi (10177537)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. NISHIKAWA Hiroyoshi (10444431)

# of Collaborated Projects: 2 results

# of Collaborated Products: 11 results
3. DOKI Yuichiro (20291445)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. NAMIKI Takeshi (50401352)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. YAGUCHI Tomonori (40424163)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. YOKOZEKI Hiroo (90210608)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
7. KATAYAMA Ichiro (80191980)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
8. KANEKO Yasuhiko (50373387)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
9. 河上裕 (50161287)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TANEMURA Atsushi 種村 篤

Research Projects

Research Products

Co-Researchers

Analysis for anti-oxidative and immune-regulatory action in vitiligo fibroblastPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis for skin microenvironmental change and character of melanocyte-specific resident T cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new strategy for cancer therapy based on RIG-I and MAVS signaling pathway

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis for melanocyte-specific T cells anargy system in autoimmune vitiligoPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of a novel molecular targeted therapy against acral melanomas

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Activation of anti-tumor immune responses by the control of regulatory T cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of suppressive mechanisms by regulatory T cells

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment in evaluating antitumor immunity of inactivated HVJ-Eto malignant melanomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Novel real-time visualization of functional vitiligo skin lymphocytes attracting melanocytes in autologous cultured epidermis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Melanocyte-specific CD49a+CD8+ T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dysregulation of circular antigen-specific T cells anergy in autoimmune vitiligo.2018

Author(s)

Journal Title

Data Source

[Journal Article] Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking anti-tumor immune responses in humans2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Recent Advance and Development in Antitumor Effect of HVJ Envelope Vector in Malignant Melanoma; from Bench to Clinical Application2013

Author(s)

Journal Title

TANEMURA Atsushi 種村篤